An Observational Study of Cholesterol in Coronary Arteries
NCT ID: NCT00831116
Last Updated: 2017-06-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
2067 participants
OBSERVATIONAL
2009-02-28
2017-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Lipid-Rich Plaque Study
NCT02033694
Assessment of Coronary Plaque Composition
NCT01581632
SPECTACL: SPECTroscopic Assessment of Coronary Lipid
NCT00330928
LipiScan- Ultrasound INterrogation of Atherosclerotic Coronary Arteries:
NCT02953613
Intravascular Near Infrared Spectroscopy (NIRS) Bifurcation - Lipid Core Plaque Shift Study
NCT00905671
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
LipiScan
Subjects who have at least one native coronary artery imaged with the LipiScan CIS.
Intravascular Near Infrared Spectroscopy
Intravascular imaging with a catheter based spectroscopy system.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Intravascular Near Infrared Spectroscopy
Intravascular imaging with a catheter based spectroscopy system.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject is scheduled for elective coronary catheterization.
* LipiScan CIS, LipiScan IVUS Imaging System, or TVC Imaging System use is not contra-indicated.
* At least one chemogram from a native coronary artery is available for submission to the registry.
* Able to read, understand and sign the informed consent.
Exclusion Criteria
* Subject life expectancy is less than 2 years at time of index catheterization.
* All submitted chemograms are obtained with the LipiScan, LipiScan IVUS, or TVC(R) Imaging Catheter positioned within a coronary artery bypass graft.
* Unable to give informed consent
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Infraredx
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Giora Weisz, MD
Role: STUDY_CHAIR
Columbia University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mercy Gilbert Medical Center
Gilbert, Arizona, United States
Scottsdale Healthcare
Scottsdale, Arizona, United States
University of California, Los Angeles Medical Center
Los Angeles, California, United States
University of California Irvine Medical Center
Orange, California, United States
San Francisco Veterans Affairs Medical Center
San Francisco, California, United States
University of Florida, Gainesville
Gainesville, Florida, United States
Pepin Heart Hospital
Tampa, Florida, United States
Piedmont Hospital
Atlanta, Georgia, United States
Washington Adventist Hospital
Takoma Park, Maryland, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Lahey Clinic
Burlington, Massachusetts, United States
Crittenton Shelton Heart Center:
Rochester Hills, Michigan, United States
William Beaumont Hospital
Royal Oak, Michigan, United States
Mayo Clinic
Rochester, Minnesota, United States
Saint Louis University Hospital
St Louis, Missouri, United States
Mount Sinai School of Medicine
New York, New York, United States
Columbia Universtiy Medical Center
New York, New York, United States
Pinnacle Heart & Vascular Institute
Harrisburg, Pennsylvania, United States
Medical University of South Carolina Hospital
Charleston, South Carolina, United States
Veterans Affairs, North Texas Health Care Systems
Dallas, Texas, United States
Swedish Medical Center
Seattle, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0111
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.